Edwards Lifesciences Corporation
$82.91
$0.42(-0.50%)
Edwards Lifesciences Corporation
EW
$82.91
$0.42(-0.50%)
Edwards Lifesciences Corporation
EW
NYSE
$82.91
$0.42(-0.50%)
Chart
Upcoming Earnings
Next report date
Jul 23, 2026
Report period
Q3 2026
EPS Estimate
$0.74
Revenue Estimate
$1.70B
Key stats
52-Week Range$82.91
$72.30
$87.89
Market capitalization
$47.80BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
44.51Basic EPS (TTM)
$1.89Net income (TTM)
$1.09BRevenue (TTM)
$6.30BAvg. volume
5.22MBeta (1Y)
0.87Employees
15.80KMarket capitalization
$47.80BDividend yield (indicated)
0.00%Price to earnings Ratio (TTM)
44.51Basic EPS (TTM)
$1.89Net income (TTM)
$1.09BRevenue (TTM)
$6.30BAvg. volume
5.22MBeta (1Y)
0.87Employees
15.80KScreener Quick Check
Sign in to check this stock against your screeners
Sign InAbout Edwards Lifesciences Corporation
Sector
Healthcare
Industry
Medical - Devices
CEO
Bernard J. Zovighian
Website
www.edwards.comHeadquarters
One Edwards Way, Irvine, CA, 92614
IPO Date
2000-03-27
Identifiers
ISIN
US28176E1082Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical...
Related Stocks
$144.17
1D:
-1.5%
1Y:
39.7%
US0758871091Healthcare
Mkt Cap
$52.23B
P/E Ratio TTM
24.2
Revenue TTM
$21.92B
Beta
0.35
Earnings TTM
$1.76B
Dividend Yield TTM
2.50%
Dividend Overview
This company does not pay dividends
Financials
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q3 '26
Actual
Estimate
Performance
Margin trends
Debt level and coverage
Earnings
Next: Q3 '26
Actual
Estimate